ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15162024
Avg. Estimate2.912.8310.9511.07
Low estimate2.762.5510.639.58
High estimate2.993.111.1412.35
Year ago EPS3.373.6613.7710.95
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts13132323
Avg. Estimate13.48B13.38B52.65B52.28B
Low estimate12.95B13.08B52B49.42B
High estimate13.67B13.65B54.19B55.16B
Year ago sales14.58B14.91B58.05B52.65B
Sales growth (year/est)-7.60%-10.20%-9.30%-0.70%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS3.313.573.562.46
Actual EPS3.373.663.62.46
Difference0.060.090.040
Surprise %1.80%2.50%1.10%0.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate2.912.8310.9511.07
7 days ago2.722.6310.1910.3
30 days ago2.922.8210.9411.04
60 days ago2.872.8311.0711.11
90 days ago2.912.8511.1311.1
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2234
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesABBVIndustrySector(s)S&P 500
Current qtr.-13.60%N/AN/AN/A
Next qtr.-22.70%N/AN/AN/A
Current year-20.50%N/AN/AN/A
Next year1.10%N/AN/AN/A
Next 5 years (per annum)-4.17%N/AN/AN/A
Past 5 years (per annum)13.15%N/AN/AN/A